New Pharmacological Target to Treat Ischemic Mitral Regurgitation: Thinking Outside the Box

Luc A Pierard; Julien Magne

doi:10.1016/j.jacc.2017.07.751

New Pharmacological Target to Treat Ischemic Mitral Regurgitation: Thinking Outside the Box

J Am Coll Cardiol. 2017 Sep 5;70(10):1245-1247. doi: 10.1016/j.jacc.2017.07.751.

Authors

Luc A Pierard¹, Julien Magne²

Affiliations

¹ Cardiology Department, University Hospital of Liege, Sart Tilman University Hospital Center, Liege, Belgium. Electronic address: lpierard@chu.ulg.ac.be.
² Limoges University Hospital Center, Cardiology Department, Dupuytren Hospital, Limoges, France; National Institute for Health and Medical Research (INSERM) 1094, Faculty of Medicine of Limoges, Limoges, France.

PMID: 28859787
DOI: 10.1016/j.jacc.2017.07.751

No abstract available

Keywords: angiotensin receptor blocker; endothelial-to-mesenchymal transformation; ischemic mitral regurgitation; mitral regurgitation; pharmacological treatment; valvular heart disease.

Publication types

Editorial
Comment

MeSH terms

Humans
Losartan
Mitral Valve
Mitral Valve Insufficiency*
Myocardial Infarction*
Myocardial Ischemia*

Substances

Losartan